New Gene Editing Treatment Cuts Dangerous Cholesterol in Small Study
The trial involved only 10 patients, but it suggests cholesterol can be permanently reduced with a single treatment for patients at risk of ...
The Bodily Indignities of the Space Life
The race is on to put hotels in space and neighborhoods on the moon. Here’s some of what we know about how Earthlings fare beyond the safety...
The Only People Who Understand What a Caregiver Goes Through
Mentoring programs bring together those just starting to care for family members with dementia and those who have been coping for some time....
Gonorrhea Is Becoming Drug Resistant. Scientists Just Found a Solution.
A new antibiotic, zoliflodacin, is as effective as the current standard of care. Its creation may hasten the arrival of other needed antibio...
Coping With Anger as a Family Caregiver
Looking after a sick family member can mean putting your own life on hold, often with little recognition or outside support. from NYT >...
A Hairy Truth About Your Sense of Touch
Researchers showed that cells in your hair follicles release important chemical messengers in response to gentle touches to your skin. fro...
F.D.A. Approves New Obesity Drug Tirzepatide That Will Compete With Wegovy
Zepbound, which is already sold by Eli Lilly as the diabetes treatment Mounjaro, was shown to reduce patients’ weight by as much as one-fift...
FDA Approves Zepbound, A Drug Like Ozempic, for Weight Loss. Here’s What to Know.
The obesity medication contains tirzepatide, the same active ingredient in the diabetes drug Mounjaro. from NYT > Health https://ift.tt...
Senate Confirms Monica Bertagnolli as NIH Director
Dr. Monica M. Bertagnolli won bipartisan approval despite opposition from Senator Bernie Sanders, the chairman of the Senate health committe...
Infants Are Born With Syphilis in Growing Numbers, a Sign of a Wider Epidemic
Congenital syphilis has become more than ten times as common over the past decade, the C.D.C. reported. “The situation is dire,” said one ex...
Subscribe to:
Posts
(
Atom
)
